Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5951–6000 of 75406
appointed each of Jason Lloyd and Kenneth Thieneman to serve as directors of the Board to fill the vacancies created by the resignations described below.
On the same date, the Board appointed Nicola Caiano to replace Ms. Halford on the Board.
On April 26, 2025, Mary Ann Halford resigned from the Board of Directors (the “Board”) of Eightco Holdings Inc. (the “Company”).
On April 22, 2025, BOXABL Inc. (the “Company”) appointed Galiano Tiramani as Co-Chief Executive Officer
Paolo Tiramani has been appointed as Executive Chairman of the Board of Directors, acting as chairperson of the Board, as well as Chief Engineering and Strategy Officer.
On April 23, 2025, Alisa Lask notified the Board of Directors (the “Board”) of Nephros, Inc. (the “Company”) that she will not stand for re-election to the Board at the Company’s annual meeting of stockholders scheduled to be held on June 16, 2025 (the “2025 Annual Meeting”).
On April 28, 2025, the Board of Directors (the “Board”) of Tharimmune, Inc. (the “Company”) increased the size of the Board to nine members and appointed each of Clay Kahler and Gary Stetz as members of the Board.
On April 28, 2025, the Board of Directors (the “Board”) of Tharimmune, Inc. (the “Company”) increased the size of the Board to nine members and appointed each of Clay Kahler and Gary Stetz as members of the Board.
Mr. Deniss Volkovs resigned from all positions within the Company.
Mr. Bong Dennis has been appointed as President, Chief Executive Officer, and Chief Financial Officer of the Company as at April 22, 2025.
Additionally, Mr. Alexandr Chiciuc, Director, also resigned.
Michael Stubblefield and Avantor, Inc. (the “Company”) agreed to initiate a leadership transition and Mr. Stubblefield agreed to step down from his role as Director, President and Chief Executive Officer of the Company, effective upon the appointment of his successor.
On April 22, 2025, Open Lending Corporation (the "Company") reassigned the duties and responsibilities of Sarah Lackey, the Company's Chief Technology Officer and a named executive officer, to other personnel within the Company.
On April 22, 2025, Michael Lee (age 52) was appointed Chief Financial Officer of Arhaus, Inc. (the “Company”), effective May 12, 2025.
Effective April 24, 2025, Carrie Schwarz stepped down as a director of the Company.
Kevin J. Wheeler will be transitioning from Chairman and Chief Executive Officer of the Company to Executive Chairman, effective July 1, 2025.
Stephen M. Shafer, the Company’s President and Chief Operating Officer, has been elected Chief Executive Officer of the Company effective July 1, 2025, in addition to serving in his capacity as President.
Mr. Shafer has also been elected to the Board of Directors effective July 1, 2025.
On April 23, 2025, the Board of Directors of IMAX Corporation (the “Company”) appointed Jose Zlatar, the Company’s Senior Vice President, Finance, to the role of principal accounting officer, effective April 30, 2025.
On April 24, 2025, the Board of Directors (the “Board”) of Spire Inc. (the “Company”) appointed Scott Doyle, currently the Chief Operating Officer of the Company and Chief Executive Officer of Spire Missouri Inc. and Spire Alabama Inc., as President and Chief Executive Officer (“CEO”) of the Company effective April 24, 2025 (the “Transition Effective Date”).
resigned as a member of the Board
On April 24, 2025, the Board also appointed Mr. Doyle as a director to serve until the 2027 Annual Meeting of Shareholders and until his successor is elected and qualified, effective as of the Transition Effective Date.
Mr. Doyle will replace Steve Lindsey, whose employment as President and CEO of the Company was terminated without “Cause” (as defined under the Company’s Executive Severance Plan) and who resigned as a member of the Board, in each case, effective as of the Transition Effective Date.
In the interim, Thomas E. Sullivan has been appointed to serve as the Company’s Interim Chief Financial Officer, effective upon Mr. Murphy’s departure.
On April 21, 2025, Timothy J. Murphy notified Repay Holdings Corporation (the “Company”) of his decision to resign as Chief Financial Officer of the Company, effective May 15, 2025.
As previously announced, on February 13, 2025 the Board appointed John D. Calys, the Company’s Senior Vice President, Global Controller and Chief Accounting Officer, to succeed its current Chief Financial Officer, George Kilguss, upon his retirement on May 31, 2025.
As previously announced, on February 13, 2025 the Board appointed John D. Calys, the Company’s Senior Vice President, Global Controller and Chief Accounting Officer, to succeed its current Chief Financial Officer, George Kilguss, upon his retirement on May 31, 2025.
Nathan Bennett, who served as the Company's Chief Accounting Officer/Interim Chief Financial Officer from January 1, 2024 to April 21, 2025, was appointed as Chief Financial Officer of the Company effective April 21, 2025.
On April 21, 2025, Christina McCarthy, a member of the board of directors (the "Board") since 2023, notified the Company that she will not stand for re-election as a director of the Company upon the expiration of her current term, which expires at the Company's 2025 Annual Meeting of Shareholders.
On April 24, 2025, the Board appointed William Paul Chawrun, age 59, as the Chief Operating Officer (the "COO") of the Company, effective April 30, 2025.
Upon Mr. Chawrun's start date, Matthew Gili will resign from his position as President and COO and will assist with the transition period, and Richard Young will assume the role of President in addition to his current position as Chief Executive Officer as previously announced in the Company's Current Report on Form 8-K as filed with the SEC on April 15, 2025.
Richard Young will assume the role of President in addition to his current position as Chief Executive Officer
On April 22, 2025, Michael J. Rugen resigned as the Chief Financial Officer of New Era Helium, Inc. (the “ Company ”) with an effective date of May 31, 2025 (the “ Effective Date ”).
The Board plans to nominate Satish Chandran, Ph.D. and Blaise Coleman for election to the Board at the 2025 Annual Meeting to replace Dr. Fernandes and Dr. Whittington.
Separately, on April 21, 2025, Marna C. Whittington, Ph.D., a member of the Board, the Compensation Committee of the Board, and a member and chair of the Audit Committee of the Board, informed the Company of her decision to not stand for re-election to the Board at the Company’s 2025 Annual Meeting.
Prabha Fernandes, Ph.D., FIDSA, a member of the Board of Directors (the “Board”) of Ocugen, Inc. (the “Company”), a member and chair of the Compensation Committee of the Board, a member of the Audit Committee of the Board and the Science and Technology Committee of the Board, informed the Company that she is resigning from the Board effective at the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
The Board plans to nominate Satish Chandran, Ph.D. and Blaise Coleman for election to the Board at the 2025 Annual Meeting to replace Dr. Fernandes and Dr. Whittington.
and Mr. Tracy Bolt as lead independent director.
appointed, effective immediately, Mr. Jeremy B. Ford as Chairman of the Board
appointed Mr. Gerald J. Ford as Chairman Emeritus effective immediately.
On April 17, 2025, Daniel Okelo resigned as our Secretary and Zig Ziegler was appointed in his place.
On April 17, 2025, Daniel Okelo resigned as our Secretary and Zig Ziegler was appointed in his place.
On April 23, 2025, the Board of Directors (the “Board”) of World Kinect Corporation (the “Company”) appointed Jeffrey M. Kottkamp as a director of the Company.
each of Alan Masarek, Shai Terem, Edward T. Anderson, Michael Medici, Paul Milbury, Carol Meyers, Antonio Rodriguez, Aaron VanDevender and George Riedel resigned from the Board and from any and all committees thereof on which they served and ceased to be directors of the Company
each of Alan Masarek, Shai Terem, Edward T. Anderson, Michael Medici, Paul Milbury, Carol Meyers, Antonio Rodriguez, Aaron VanDevender and George Riedel resigned from the Board and from any and all committees thereof on which they served and ceased to be directors of the Company
Julien Lederman and Ofir Baharav, who constituted the directors of Merger Sub as of immediately prior to the Effective Time, became the directors of the Company
each of Alan Masarek, Shai Terem, Edward T. Anderson, Michael Medici, Paul Milbury, Carol Meyers, Antonio Rodriguez, Aaron VanDevender and George Riedel resigned from the Board and from any and all committees thereof on which they served and ceased to be directors of the Company
each of Alan Masarek, Shai Terem, Edward T. Anderson, Michael Medici, Paul Milbury, Carol Meyers, Antonio Rodriguez, Aaron VanDevender and George Riedel resigned from the Board and from any and all committees thereof on which they served and ceased to be directors of the Company
In connection with the Merger, as of the Effective Time, Shai Terem resigned from his role as Chief Executive Officer and President of the Company
each of Alan Masarek, Shai Terem, Edward T. Anderson, Michael Medici, Paul Milbury, Carol Meyers, Antonio Rodriguez, Aaron VanDevender and George Riedel resigned from the Board and from any and all committees thereof on which they served and ceased to be directors of the Company
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.